modulate inflammatory responses, the acquired immune response, and to improve patient outcomes [34].
Personalized immunonutrition for patients with obesity should be the first therapeutic choice to reduce the risk of infections and the disease course in COVID-19 patients. That therapeutic strategy could be effecti